BioMed Research International

Biomarkers in Women’s Cancers, Gynecology, and Obstetrics


Publishing date
02 May 2014
Status
Published
Submission deadline
13 Dec 2013

1Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg, Comprehensive Cancer Center EMN, Erlangen, Germany

2Department of Medicine, Division of Hematology-Oncology, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA

3Molecular Cancer Epidemiology Laboratory, Genetics and Population Health Division, Queensland Institute of Medical Research, Royal Brisbane Hospital Post Office, Herston, QLD, Australia


Biomarkers in Women’s Cancers, Gynecology, and Obstetrics

Description

The evolution of biomarkers in many diseases has changed diagnostic and therapeutic standards over the last decades. Especially after the publication of the reference genome about 10 years ago, many molecular methods have been developed that have led to the discovery of major pathways in the pathogenesis and the progression of many diseases. Main discoveries have been made in the field of cancer research; however, the application of novel technologies to other diseases in gynecology and obstetrics has shown advancements that are of great potential to improve clinical diagnostics, therapeutics, and patient care. Recently the implementation of new therapies together with companion diagnostics promises to identify patients that will have a specifically high response rate to the applied therapies along with rarer side effects.

We invite investigators to contribute with original research papers as well as review papers that will stimulate the understanding of biomarker use in women’s cancers, gynecology, and obstetrics. We are particularly interested in papers describing the use of biomarkers in clinical and preclinical settings. They should aim at the advancement of molecular genetics and molecular diagnostics and provide new insights into the future of biomarker use in women’s cancers, gynecology, and obstetrics. Potential topics include, but not limited to:

  • Recent developments in prediction of disease risk for healthy women
  • Advances in the use of biomarkers in the field of obstetrics
  • Latest technologies for the discovery of biomarkers
  • Role of signal transduction pathways in women’s cancers, gynecology, and obstetrics
  • Biomarkers for the prognosis and severity of diseases
  • Companion diagnostics for novel therapies
  • Recent advances in biomarker use within clinical trials

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/obgyn/bwc/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 602340
  • - Editorial

Biomarkers in Women’s Cancers, Gynecology, and Obstetrics

Peter A. Fasching | Gottfried E. Konecny | Amanda B. Spurdle
  • Special Issue
  • - Volume 2014
  • - Article ID 415721
  • - Review Article

Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients

Natalia Krawczyk | Franziska Meier-Stiegen | ... | Tanja Fehm
  • Special Issue
  • - Volume 2014
  • - Article ID 140851
  • - Research Article

Estimating Rate of Insulin Resistance in Patients with Preeclampsia Using HOMA-IR Index and Comparison with Nonpreeclampsia Pregnant Women

Farideh Rezaei Abhari | Maryam Ghanbari Andarieh | ... | Soleiman Ahmady
  • Special Issue
  • - Volume 2014
  • - Article ID 491459
  • - Research Article

Evaluation of Two Different Analytical Methods for Circulating Tumor Cell Detection in Peripheral Blood of Patients with Primary Breast Cancer

B. A. S. Jaeger | J. Jueckstock | ... | B. Rack
  • Special Issue
  • - Volume 2014
  • - Article ID 379847
  • - Research Article

Macrophage Capping Protein CapG Is a Putative Oncogene Involved in Migration and Invasiveness in Ovarian Carcinoma

J. Glaser | M. H. D. Neumann | ... | M. C. Fleisch
  • Special Issue
  • - Volume 2014
  • - Article ID 702848
  • - Research Article

Meconium Indicators of Maternal Alcohol Abuse during Pregnancy and Association with Patient Characteristics

Tamme W. Goecke | Pascal Burger | ... | Johannes Kornhuber
  • Special Issue
  • - Volume 2014
  • - Article ID 807196
  • - Review Article

First Trimester Biomarkers in the Prediction of Later Pregnancy Complications

Stefan C. Kane | Fabricio da Silva Costa | Shaun Brennecke
  • Special Issue
  • - Volume 2014
  • - Article ID 628217
  • - Research Article

Can Ki-67 Play a Role in Prediction of Breast Cancer Patients' Response to Neoadjuvant Chemotherapy?

Juhasz-Böss Ingolf | Mavrova Russalina | ... | Herr Daniel
  • Special Issue
  • - Volume 2014
  • - Article ID 137304
  • - Research Article

Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry

E. C. Inwald | O. Ortmann | ... | M. Klinkhammer-Schalke
  • Special Issue
  • - Volume 2014
  • - Article ID 469278
  • - Research Article

Genetic Variants in the Genes of the Stress Hormone Signalling Pathway and Depressive Symptoms during and after Pregnancy

Michael Schneider | Anne Engel | ... | Stefanie Burghaus
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit